Bio-Path Holdings Announces $4M Private Placement Of 1,809,955 Shares Of Its Common Stock, Series A Warrants To Purchase Up To 1,809,955 Shares Of Common Stock And Short-Term Series B Warrants To Purchase Up To 1,809,955 Shares Of Common Stock At A Purchase Price Of $2.21
Portfolio Pulse from Benzinga Newsdesk
Bio-Path Holdings, Inc. (NASDAQ:BPTH) announced a $4M private placement involving the issuance of 1,809,955 shares of common stock, series A warrants, and short-term series B warrants at a purchase price of $2.21 per share. The series A and B warrants will have an exercise price of $2.00 per share. The closing is expected around June 5, 2024, with H.C. Wainwright & Co. as the exclusive placement agent.
June 04, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bio-Path Holdings announced a $4M private placement involving shares and warrants priced at $2.21 each. This move is likely to provide the company with additional capital but may dilute existing shareholders.
The private placement will provide Bio-Path Holdings with additional capital, which is positive for the company's financial health. However, the issuance of new shares and warrants may dilute the value of existing shares, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100